Testosterone Replacement Therapy Market Report 2024 (Global Edition)

Global Testosterone Replacement Therapy Market Report 2024 Market Size Split by Product type (Injectables, Topical, Others), by Active Ingredients (Testosterone, Testosterone Undecanoate, Testosterone...

Testosterone Replacement Therapy Market Report Description

We have various report editions of Testosterone Replacement Therapy Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Testosterone Replacement Therapy Market Insights Video

Competitive Landscape of the Testosterone Replacement Therapy Market

The competitive landscape of the testosterone replacement therapy market, with well-known healthcare technology companies, new companies, and telehealth services operating. Within this quickly expanding field, testosterone therapy companies concentrate on coming up with new ideas, combining advanced technology, and building strategic partnerships to improve their therapy strategy and increase their market share. Key players in the market include AbbVie Inc., Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company plc., Cipla Inc., Lupin, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC, Braeburn Inc., Johnsons & Johnsons Services Inc., Boehringer Ingelheim International GmbH, Allergan, Sun Pharmaceutical Industries Ltd., Sanofi, AstraZeneca, GlaxoSmithKline Plc., Novartis AG, Pfizer Inc., Amneal Pharmaceuticals LLC., and Alvogen.

July 2024: Launch Therapeutics, Inc. and Teva Pharmaceutical Industries Ltd. signed a clinical collaboration deal today to speed up the clinical research program for Teva’s ICS-SABA (TEV-‘248) even more. Teva and Abingworth, a leading international life sciences investment group and a part of the global investment company Carlyle, also announced a strategic development funding agreement today. Under the agreement, Abingworth will give Teva up to $150 million to help pay for its ICS/SABA (TEV-‘248) program. (Source:https://www.tevapharm.com/news-and-media/latest-news/clinical-collaboration-agreement-between-teva-and-launch-therapeutics-to-accelerate-development-of-dual-a/ August 2024: Perrigo Company plc, a major company that makes consumer self-care products, announced that the Women’s National Basketball Association (WNBA) and Opill®, the first daily birth control pill that can be bought without a prescription in the U.S., have formed a multi-year partnership to promote health equity, confidence, and strength, which are all important goals for both groups. (Source:https://www.perrigo.com/media-release/opill-and-wnba-team-groundbreaking-partnership July 2024: Hikma Pharmaceuticals PLC, a global pharmaceutical company, announced an acquisition. The acquisition will include Xellia Pharmaceuticals’ US finished dosage form business and assets, including a commercial portfolio and pipeline of differentiated products, a manufacturing facility in Cleveland, Ohio, sales and marketing capabilities, and an R&D center in Zagreb, Croatia. Xellia Pharmaceuticals is a Copenhagen-based specialty company that specializes in providing anti-infective treatments and other critical care therapies. (Source:https://www.hikma.com/news/hikma-acquires-xellia-s-differentiated-portfolio-and-enhances-injectables-pipeline-manufacturing-capabilities-and-rd/)

Top Companies Market Share in Testosterone Replacement Therapy Industry: (In no particular order of Rank)

• AbbVie Inc.
• Bausch Health Companies Inc.
• Teva Pharmaceutical Industries Ltd.
• Perrigo Company plc
• Cipla Inc.
• Lupin
• Sun Pharmaceuticals Industries Ltd.
• Hikma Pharmaceuticals PLC
• Braeburn Inc.
• Johnsons & Johnsons Services Inc.
• Boehringer Ingelheim International GmbH
• Allergan
• Sun Pharmaceutical Industries Ltd.
• Sanofi
• AstraZeneca
• GlaxoSmithKline Plc.
• Novartis AG
• Pfizer Inc.
• Amneal Pharmaceuticals LLC.
• Alvogen
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Testosterone Replacement Therapy Market

Which Region Dominates the Testosterone Replacement Therapy Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue because of better healthcare infrastructure, people being well-informed about the available treatments, healthcare being well-developed, and there being a significant demand for men’s health products. Testosterone replacement therapies are becoming increasingly popular.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the testosterone replacement therapy market because of the aging population, increasing healthcare costs, and the growing awareness of testosterone shortage. Additionally, rising incomes in the region’s middle class and better healthcare accessibility are other factors propelling demand. Moreover, the increasing emphasis on men’s health and government programs that encourage better healthcare are driving market expansion in the Asia Pacific area.

The current report Scope analyzes Testosterone Replacement Therapy Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Testosterone Replacement Therapy Market

According to Cognitive Market Research, the global testosterone replacement therapy market size was estimated at USD 2142.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 857.04 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the testosterone replacement therapy market with a market size of USD 676.20 million in 2024 and is projected to grow at a CAGR of 2.5% during the forecast period. The nation's advancements in healthcare technology.
• The Canada testosterone replacement therapy market had a market share of USD 102.84 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. Canada's strict government healthcare rules in developing nations.
• The Mexico testosterone replacement therapy market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 77.99 million in 2024.

Europe Testosterone Replacement Therapy Market

According to Cognitive Market Research, the global testosterone replacement therapy market size was estimated at USD 2142.6 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 642.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.0% from 2024 to 2031.

• The United Kingdom testosterone replacement therapy market had a market share of USD 107.99 million in 2024 and is projected to grow at a CAGR of 3.8% during the forecast period. In the UK, testosterone replacement therapy sales witness an upswing due to the nation's rising demand for this technology.
• The France testosterone replacement therapy market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD 59.14 million in 2024.
• According to Cognitive Market Research, the German testosterone replacement therapy market size was valued at USD 127.27 million in 2024 and is projected to grow at a CAGR of 3.2% during the forecast period. In Germany, testosterone replacement therapy surged due to the presence of major market players.
• The Italy testosterone replacement therapy market is projected to witness growth at a CAGR of 2.4% during the forecast period, with a market size of USD 55.28 million in 2024.
• The Russia testosterone replacement therapy market is projected to witness growth at a CAGR of 2.0% during the forecast period, with a market size of USD 99.63 million in 2024.
• The Spain testosterone replacement therapy market is projected to witness growth at a CAGR of 2.1% during the forecast period with a market size of USD 52.71 million in 2024
• The Luxembourg testosterone replacement therapy market is projected to witness growth at a CAGR of 3.1% during the forecast period, with a market size of USD 19.93 million in 2024.
• The Portugal testosterone replacement therapy market is projected to witness growth at a CAGR of 2.8% during the forecast period, with a market size of USD 13.50 million in 2024.
• The Greece testosterone replacement therapy market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD 7.71 million in 2024.
• Rest of Europe's testosterone replacement therapy market is projected to witness growth at a CAGR of 1.7% during the forecast period, with a market size of USD 99.63 million in 2024.

Asia Pacific Testosterone Replacement Therapy Market

According to Cognitive Market Research, the global testosterone replacement therapy market size was estimated at USD 2142.6 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 492.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.

• According to Cognitive Market Research, the China testosterone replacement therapy market size was valued at USD 221.76 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Testosterone replacement therapy surged in China due to the rising aging male population.
• The Japan testosterone replacement therapy market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 68.01 million in 2024.
• The India testosterone replacement therapy market had a market share of USD 59.14 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. India's supportive medical initiatives taken by the government.
• The South Korean testosterone replacement therapy market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 49.28 million in 2024.
• The Australian testosterone replacement therapy market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 25.63 million in 2024.
• The Southeast Asia testosterone replacement therapy market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 34.00 million in 2024.
• The Rest of Asia Pacific testosterone replacement therapy market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 34.99 million in 2024.

South America Testosterone Replacement Therapy Market

According to Cognitive Market Research, the global testosterone replacement therapy market size was estimated at USD 2142.6 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 107.13 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil testosterone replacement therapy market size was valued at USD 48.45 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. Testosterone replacement therapy has flourished in Brazil due to innovations in medical technology.
• Argentina's testosterone replacement therapy market had a market share of USD 18.00 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. Argentina's technological advancements augment the demand.
• Colombia’s testosterone replacement therapy market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 9.53 million in 2024.
• Peru’s testosterone replacement therapy market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 8.78 million in 2024.
• Chile’s testosterone replacement therapy market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 7.71 million in 2024.
• The Rest of Latin America's testosterone replacement therapy market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 17.24 million in 2024.

Middle East and Africa Testosterone Replacement Therapy Market

According to Cognitive Market Research, the global testosterone replacement therapy market size was estimated at USD 2142.6 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 42.85 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031..

• The GCC Countries’ testosterone replacement therapy market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 18.34 million in 2024. Testosterone replacement therapy sales flourish due to the presence of major market players.
• The Egypt testosterone replacement therapy market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 4.50 million in 2024.
• The South Africa testosterone replacement therapy market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 6.77 million in 2024. Testosterone replacement therapy sales flourish in South Africa due to technological advancements, increasing healthcare demand, and regulatory support.
• The Turkey testosterone replacement therapy market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 3.69 million in 2024.
• The Nigeria testosterone replacement therapy market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD 4.50 million in 2024.
• The Rest of the MEA testosterone replacement therapy market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 5.06 million in 2024.

Testosterone Replacement Therapy Market Analysis

Testosterone Replacement Therapy Market Product Type Segment Analysis

According to Cognitive Market Research, injectables stand out as the dominant category over the projected period because, in comparison to other forms, they provide more stable testosterone levels, longer-lasting effects, and accurate dosing. Additionally, they are the go-to for treating testosterone shortage because of their familiarity among healthcare providers, their effectiveness, and their extensive use.

Topical emerges as the fastest-growing category in the testosterone replacement therapy market due to the non-invasive nature, ease of usage, and convenience they provide. Because of their self-administerability and dose flexibility, topical options are preferred by patients, who subsequently exhibit higher rates of adherence and broad use of these treatments, which is fueling the rapid expansion of this market as testosterone replacement therapy.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Testosterone Replacement Therapy Industry. Request a Free Sample PDF!

Testosterone Replacement Therapy Market Active Ingredients Segment Analysis

According to Cognitive Market Research, the dominant category is testosterone undecanoate due to the fact that its formulation is long-acting. It so requires less frequent dosing than other types. Additionally, this is a favorite among patients and healthcare providers alike because it eases medication adherence, delivers consistent testosterone levels, and decreases patient burden.

The fastest-growing category in the testosterone replacement therapy market is testosterone cypionate because of its effectiveness in treating testosterone insufficiency, low cost, and broad availability. Furthermore, its patient-friendly nature stems from its substantially longer half-life, which permits less frequent dosing. Strong physician preference and patient familiarity also play a role in its fast market growth.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Testosterone Replacement Therapy End-User Segment Analysis

Testosterone replacement therapy Market End-User Segment Analysis

According to Cognitive Market Research, the dominant category is hospitals because they provide complete treatment, including precise diagnosis, tailored therapy, and continuous monitoring for testosterone insufficiency. In addition, modern medical technologies and seasoned healthcare specialists are available in hospitals, so guaranteeing safe and efficient therapy. Furthermore, hospitals drive their popularity In the market because they usually act as main treatment facilities for serious conditions.

The fastest-growing category in the testosterone replacement therapy market is clinics because they provide greater accessibility and individual attention to patients. Clinics provide a spectrum of services that are designed with patients in mind, such as personalized treatment regimens and continuous monitoring. In addition, more and more men are turning to them for testosterone replacement therapy because of their accommodating schedules and emphasis on outpatient care.

• Hospital
• Clinics

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion